| Kimberly Ann Hyatt, SOCIAL WORKER | |
|
Unit 33100, Apo, AE 09180-3100 | |
| (314) 590-4584 | |
| Not Available |
| Full Name | Kimberly Ann Hyatt |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | Unit 33100, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821242454 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 6464 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Ann Hyatt, SOCIAL WORKER Unit 33100, Apo, AE 09180-3100 Ph: () - | Kimberly Ann Hyatt, SOCIAL WORKER Unit 33100, Apo, AE 09180-3100 Ph: (314) 590-4584 |
News Archive
Azoi, a technology company dedicated to helping people improve their lives, today announced Wello – an innovative health monitoring device embedded within a mobile phone case. With just a few powerful sensors, Wello fits onto a smartphone and measures a number of key vitals including blood pressure, electrocardiography (ECG), heart rate, blood oxygen, temperature, lung functions and more – with a high level of accuracy. Fast and easy-to-use, Wello empowers people to track key data, improve awareness of their body's state, and make more informed lifestyle choices.
Engineers at Saarland University have taken a leaf out of nature's book by equipping an artificial hand with muscles made from shape-memory wire. The new technology enables the fabrication of flexible and lightweight robot hands for industrial applications and novel prosthetic devices.
Patients with opioid use disorder receiving treatment with opioid agonists (medications such as methadone or buprenorphine) had an 80 percent lower risk of dying from an opioid overdose compared to patients in treatment without the use of medications.
The Huntington Study Group (HSG), under the leadership of Ray Dorsey, M.D. with Johns Hopkins Medical and Diana Rosas, M.D. with Massachusetts General Hospital, is conducting a clinical trial in Huntington's disease (HD) throughout the United States and Australia, "A randomized, double-blind, placebo-controlled, study to assess the safety and tolerability, and efficacy of PBT2 in patients with early to mid-stage Huntington's disease" comparing a 100 mg dose or 250 mg dose versus placebo.
› Verified 6 days ago
Heather R Baral, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Unit 23746, Apo, AE 09034 Phone: 160-209-0423 | |
Linda Riddle, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 86 Mdg Unit 3215, Apo, AE 09094 Phone: 314-479-2666 | |
Mark Wesseler, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-2015 | |
Mrs. Thin Phyu Bur, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 852 Mds/sg, Unit 3503, Apo, AE 09104 Phone: 314-458-3378 | |
Andrea Lynne Galeucia, LICSW; BCD Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 86 Mdg, Unit 3215, Ramstein Ab, Apo, AE 09094 Phone: 314-479-2390 | |
Mrs. Katheryn Rose Barry, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: Unit 3240 Box 445, Apo, AE 09094 Phone: 063-714-76951 | |
Johanna Echigo, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Psc 2 Box 11102, Apo, AE 09012 Phone: 314-479-2390 |